Hospital M&A hit a six-year high in Q1 2026 with 22 newly announced transactions carrying combined transacted revenue of $14.5 billion — the highest Kaufman Hall has recorded…
Health system revenue cycle leaders are reporting measurable AI results in 2026 — not from replacing staff, but from deploying it as a proactive prevention layer. At a…
Waystar generated $313.9 million in Q1 2026 revenue, up 22% year-over-year, as the company advances a strategy of deploying AI-powered agentic workflows to automate the approximately $100 billion…
Several DSOs are diversifying beyond acquisitions by ramping up de novo practice development, a shift driven by tighter deal supply, valuation pressure, and the operational appeal of building…
Enhanced ACA premium subsidies expired at the end of 2025, and major health systems are now reporting the financial fallout in Q1 earnings. HCA Healthcare saw a 15%…
Over 80 million Americans lack dental insurance — and many are already patients at DSO-affiliated practices. Dental membership programs convert uninsured patients into recurring revenue by bundling preventive…
Multi-specialty platforms — organizations consolidating multiple clinical disciplines under one management structure and financial model — are attracting serious private equity capital alongside single-specialty supergroups. The Bloom Organization…
Becker’s Hospital Review is tracking 21 health systems that have terminated or are exiting Medicare Advantage contracts in 2026, citing persistent prior authorization denials and inadequate reimbursement from…
Universal Health Services reported Q1 2026 volume declines in both its acute care and behavioral health divisions, driven by a weak respiratory season and winter storms. Despite the…
DSOs that absorbed 8%–20% price hikes from recent tariff and inflation cycles face margin pressure that will not recover through volume growth alone. This analysis identifies five procurement…
